Mylan to buy Agila Specialties from Strides for $1.6bn

Generic drugmaker Mylan Inc said it would buy Agila Specialties from Strides Arcolab Ltd for USD 1.6 billion to expand its injectable drugs business.

February 28, 2013 / 09:36 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Generic drugmaker Mylan Inc said it would buy Agila Specialties from Strides Arcolab Ltd for USD 1.6 billion to expand its injectable drugs business.

Mylan, one of the world's largest generic drugmakers with more than 1,100 products, said the acquisition is expected to immediately add to Mylan's adjusted diluted earnings per share following closing.

Mylan said the deal was unanimously approved by its board.

first published: Feb 28, 2013 04:26 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347